Adenovirus-vectored vaccines

Chawla, Tanu ; Khanna, Navin ; Swaminathan, Sathyamangalam (2008) Adenovirus-vectored vaccines Expert Opinion on Therapeutic Patents, 18 (3). pp. 293-307. ISSN 1354-3776

Full text not available from this repository.

Official URL:

Related URL:


Background: Engineered adenoviruses are being increasingly explored as immunoprophylactic or immunotherapeutic vaccine vectors. Encouraging data from preclinical studies using human adenovirus vectors carrying different antigen genes have resulted in many currently ongoing clinical trials. Objective: The article seeks to review the current status of the use of adenoviruses as vaccine vectors. Methods: This review is based on the patent literature since 2000 pertaining to the development of adenovirus vaccine vectors for infectious and non-infectious diseases. Conclusion: Human adenovirus-vectored vaccines have important limitations that stem from their immunogenicity and restrict their utility. This has spurred intensive efforts to find alternative adenovirus vectors and strategies, each with its own advantages and shortcomings.

Item Type:Article
Source:Copyright of this article belongs to Taylor & Francis Group.
Keywords:Adenovirus, AIDS, Dengue, Malaria, Prior Immunity, Tuberculosis, Vaccines
ID Code:109081
Deposited On:09 Mar 2018 12:12
Last Modified:09 Mar 2018 12:12

Repository Staff Only: item control page